- Waldenström Macroglobulinemia
- Melanoma
- Bladder Cancer
- Brain Cancer
- Breast Cancer
- Childhood Cancers
- Gastric Cancer
- Gynecologic Cancer
- Head & Neck Cancer
- Immunotherapy
- Kidney Cancer
- Leukemia
- Liver Cancer
- Lung Cancer
- Lymphoma Cancer
- Mesothelioma
- MPN
- MDS
- Myeloma
- Prostate Cancer
- Rare Cancers
- Sarcoma
- Skin Cancer
- Testicular Cancer
- Thyroid Cancer
Hockey Player Announces His Cancer Is In Remission
Brian Boyle, who plays center for the New Jersey Devils, has announced that his blood cancer is in remission.
Brian Boyle, who plays center for the New Jersey Devils, has announced that his blood cancer is in remission.
Boyle, 33, announced in October 2018 that there was no longer evidence in his blood of chronic myeloid leukemia. He received his diagnosis in September 2017, ESPN reported on its website.
NHL.com shared Boyle’s announce­ment: “A test (BCR-ABL) looks for the leukemia cells in your blood, and when I was first diagnosed, it was at 75 percent. At the end of last season, it was at 0.08 percent, and in July I was 0.04 percent. The results showed all zeros on Monday. It’s full molecular remission, and I feel really good.”
Boyle said he will continue to take a tar­geted medicine once a month to keep the cancer at bay and will be checked regularly by doctors, both websites reported.
He played in 69 games while undergoing treatment, ESPN stated, and was awarded the 2018 Bill Masterton Memorial Trophy for “perseverance, sportsmanship, and dedica­tion to hockey.”
MLB VP Reveals Cancer Diagnosis, Jaxon-Smith Njigba Raises Awareness for Cancer Foundation and More
December 8th 2023As Billy Bean, MLB VP, revealed a cancer diagnosis and Toronto Blue Jays sportscaster, Jamie Campbell showed pre-skin cancer photo, here is what’s happening in the oncology space this week.
Read More
FDA Biologics License Application Filed for Obe-Cel for Adult R/R B-ALL
November 29th 2023Following promising study results, a Biologics License Application has been filed with the FDA for obe-cel (obecabtagene autoleucel), a CAR-T cell therapy for patients with relapsed/refractory (r/r) adult B-cell acute lymphoblastic leukemia (ALL).
Read More
